Results 31 to 40 of about 3,833 (193)

Risk-Stratified and Response-Adapted Therapy for Pediatric Hodgkin Lymphoma in Argentina: The GATLA Experience. [PDF]

Adv Hematol
Background: The international cooperation between GATLA and AHOPCA with the support of St. Jude led to the adoption of the OEPA/COPDAC as a strategy to improve outcomes in high risk (HR) patients with HL. This study also includes the ABVD regimen for intermediate risk (IR) and low risk (LR) patients. Methods: Patients were stratified by predefined risk
Veron D, Streitenberger P, Matus M, Negri Aranguren P, Costa A, Morell D, Terrasa S, Castellanos EM, de Alarcon P, Dibar E, Makiya M.   +10 more
europepmc   +2 more sources

Hodgkin disease of thymic origin [PDF]

, 2002
J Thorac Cardiovasc Surg 2002;123:1208 ...
Calvo, María José Roca, Fernández, Pedro José Galindo, Lanzas, Juan Torres, Paricio, Pascual Parrilla, Zambudio, Antonio Ríos   +4 more
core   +3 more sources

Targeted Drug Delivery of Anticancer Agents Using C₅N₂ Substrate: Insights from Density Functional Theory

Chemistry
Cancer has a threatening impact on human health, and it is one of the primary causes of fatalities worldwide. Different conventional treatments have been employed to treat cancer, but their non-specific nature reduces their therapeutic efficacy.
Syeda Huda Mehdi Zaidi, Muhammad Ajmal, Muhammad Ali Hashmi, Ahmed Lakhani   +3 more
doaj   +1 more source

The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma [PDF]

, 2018
Background: The use of alkylating agents such as temozolomide in association with radiotherapy (RT) is the therapeutic standard of glioblastoma (GBM).
Chen, Yi, Colapietro, Alessandro, Cristiano, Loredana, Delle Monache, Simona, Festuccia, Claudio, Gravina, Giovanni Luca, Mancini, Andrea, Marampon, Francesco, Mehrling, Thomas, Pompili, Simona, Tombolini, Vincenzo, Vetuschi, Antonella, Vitale, Flora   +12 more
core   +2 more sources

DNA repair modulates the vulnerability of the developing brain to alkylating agents [PDF]

, 2008
Neurons of the developing brain are especially vulnerable to environmental agents that damage DNA (i.e., genotoxicants), but the mechanism is poorly understood.
A. Olivas, Ahles, Allan, Bobola, Brewer, Briegert, Butler, Cai, Churchwell, D. Doerge, De Alencar, Dumenco, Eizirik, Engelward, Everson, Friedberg, G.E. Kisby, Gerson, Glassner, Gleeson, Gonzaga, Harrison, Humphreys, Kagami, Kaina, Kisby, Kisby, Kisby, Kisby, Kleihues, L.D. Samson, Larsen, Lawley, Loeber, Ludlum, Lyras, M. Churchwell, M.S. Turker, Maor-Shoshani, Matijasevic, Matsumoto, Matsumoto, McHugh, McHugh, Mecocci, Mecocci, Meira, Moller, Mulhern, Nishioka, Passagne, Perera, Perera, Perera, Povirk, Rinne, Roth, S.L. Gerson, Sarkar, Sedgwick, Silber, Springer, T. Park, Tang, Tokuda, Valadez, Wang, White, Wijen, Wong, Wu   +70 more
core   +1 more source

Dermatology nurses' job description : Literature review [PDF]

, 2018
This is the first dedicated reviews to synthesize the role of dermatology nurses for multiple dermatologic conditions. The results of this review utilizing systematic approach strongly supports the specific job description of the dermatology nurses ...
Chukwu, Rita, Mankila, Johanna
core  

Preventing hereditary cancers caused by opportunistic carcinogens [PDF]

, 2011
Objectives Previous studies reported inherited BRCA1/2 deficits appear to cause cancer by impairing normal protective responses to some carcinogens.
Bernard Friedenson
core   +2 more sources

Brentuximab Vedotin‐Induced Rash Sparing CD30‐Positive Mycosis Fungoides Lesions

JEADV Clinical Practice, EarlyView.
ABSTRACT Brentuximab vedotin (BV) is an effective treatment for CD30‐positive lymphomas, including mycosis fungoides (MF). However, its use can be associated with various cutaneous adverse effects, including rashes. This case describes a 60‐year‐old male with stage IIB MF who developed a drug‐induced erythematous rash after three infusions of BV ...
Isabel Hariri, Alexander H. Enk, Jessica C. Hassel   +2 more
wiley   +1 more source

Absolute monocyte count and lymphocyte-monocyte ratio predict outcome in nodular sclerosis Hodgkin lymphoma: Evaluation based on data from 1450 patients [PDF]

, 2015
Objective: To verify whether absolute monocyte count (AMC) and lymphocyte-monocyte ratio (LMR) at diagnosis are valid prognostic parameters in classical Hodgkin lymphoma (cHL).
Aviv, Ariel, Baldini, Luca, BARI, Alessia, Cascavilla, Nicola, Cox, Maria Christina, FEDERICO, Massimo, FERRI, Paola, Gobbi, Paolo G., Iannitto, Emilio, MARCHESELLI, Luigi, Polliack, Aaron, POZZI, Samantha, SACCHI, Stefano, Tadmor, Tamar   +13 more
core   +1 more source

Mechlorethamine Hydrochloride Gel in the Treatment of Mycosis Fungoides–Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Focus on Patient Selection and Special Considerations

Cancer Management and Research, 2022
Caitlin Crimp,1 Ameya Gangal,2 Erica S Tarabadkar,3 Michi M Shinohara1,4 1Division of Dermatology, University of Washington, Seattle, WA, USA; 2School of Medicine, Emory University, Atlanta, GA, USA; 3Department of Dermatology, Emory University School of
Crimp C, Gangal A, Tarabadkar ES, Shinohara MM   +3 more
doaj